News and Analysis
Innovation, Technology, and IP News
Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...
The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma
Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...
Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says
Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...
FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications
Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...
Feed tagged as "depression treatment":
Selective serotonin reuptake inhibitors (SSRIs) are well known for their use in treating numerous central nervous system disorders, including depression and panic... Read More »
A study of patients with Parkinson’s disease has demonstrated that newer antidepressants are effective in relieving symptoms of depression without worsening... Read More »
Electroconvulsive therapy (ECT) was introduced in the 1930s as a psychiatric treatment for patients suffering from severe depression. Because this method... Read More »
Researchers at the Swedish medical university Karolinska Institutet have discovered a way in which a substance called D-serine, secreted by astrocytes, support cells... Read More »
Canada’s Centre for Addiction and Mental Health has found that employees treated for depression are more likely to be highly productive. This study testing the... Read More »
